Shufro Rose & Co. LLC Sells 25 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

Shufro Rose & Co. LLC trimmed its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 0.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 8,667 shares of the healthcare conglomerate’s stock after selling 25 shares during the quarter. Shufro Rose & Co. LLC’s holdings in UnitedHealth Group were worth $4,370,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds also recently modified their holdings of the business. Bray Capital Advisors lifted its position in UnitedHealth Group by 0.5% in the third quarter. Bray Capital Advisors now owns 9,616 shares of the healthcare conglomerate’s stock worth $4,848,000 after purchasing an additional 50 shares during the period. Asset Management One Co. Ltd. lifted its position in UnitedHealth Group by 0.5% in the third quarter. Asset Management One Co. Ltd. now owns 479,578 shares of the healthcare conglomerate’s stock worth $241,798,000 after purchasing an additional 2,245 shares during the period. Warren Street Wealth Advisors LLC lifted its position in UnitedHealth Group by 10.3% in the third quarter. Warren Street Wealth Advisors LLC now owns 783 shares of the healthcare conglomerate’s stock worth $395,000 after purchasing an additional 73 shares during the period. Blue Fin Capital Inc. raised its stake in UnitedHealth Group by 1.6% during the third quarter. Blue Fin Capital Inc. now owns 14,861 shares of the healthcare conglomerate’s stock worth $7,493,000 after acquiring an additional 234 shares in the last quarter. Finally, WestEnd Advisors LLC raised its stake in UnitedHealth Group by 9.6% during the third quarter. WestEnd Advisors LLC now owns 72,726 shares of the healthcare conglomerate’s stock worth $36,668,000 after acquiring an additional 6,360 shares in the last quarter. 87.86% of the stock is owned by institutional investors.

Analysts Set New Price Targets

UNH has been the subject of several recent analyst reports. Royal Bank of Canada dropped their price objective on UnitedHealth Group from $596.00 to $555.00 and set an “outperform” rating for the company in a research note on Wednesday, April 17th. Deutsche Bank Aktiengesellschaft increased their price objective on UnitedHealth Group from $545.00 to $562.00 and gave the stock a “buy” rating in a research note on Friday, April 19th. TD Cowen dropped their price objective on UnitedHealth Group from $607.00 to $546.00 and set a “buy” rating for the company in a research note on Wednesday, April 10th. Erste Group Bank restated a “hold” rating on shares of UnitedHealth Group in a research note on Wednesday, March 13th. Finally, Barclays raised their target price on UnitedHealth Group from $534.00 to $560.00 and gave the company an “overweight” rating in a research note on Wednesday, April 17th. Four research analysts have rated the stock with a hold rating and fifteen have issued a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average target price of $570.05.

Insider Activity

In other news, EVP Erin Mcsweeney sold 1,236 shares of UnitedHealth Group stock in a transaction dated Friday, March 8th. The stock was sold at an average price of $483.48, for a total transaction of $597,581.28. Following the transaction, the executive vice president now owns 9,364 shares in the company, valued at approximately $4,527,306.72. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. In related news, CAO Thomas E. Roos sold 858 shares of UnitedHealth Group stock in a transaction that occurred on Friday, February 23rd. The stock was sold at an average price of $525.79, for a total value of $451,127.82. Following the sale, the chief accounting officer now owns 32,289 shares of the company’s stock, valued at approximately $16,977,233.31. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, EVP Erin Mcsweeney sold 1,236 shares of the business’s stock in a transaction that occurred on Friday, March 8th. The stock was sold at an average price of $483.48, for a total value of $597,581.28. Following the transaction, the executive vice president now directly owns 9,364 shares in the company, valued at approximately $4,527,306.72. The disclosure for this sale can be found here. 0.35% of the stock is currently owned by company insiders.

UnitedHealth Group Trading Up 0.3 %

UNH traded up $1.49 during midday trading on Friday, reaching $495.35. 2,727,016 shares of the company were exchanged, compared to its average volume of 5,623,667. The company has a debt-to-equity ratio of 0.69, a quick ratio of 0.79 and a current ratio of 0.85. UnitedHealth Group Incorporated has a one year low of $436.38 and a one year high of $554.70. The stock has a market capitalization of $455.76 billion, a P/E ratio of 30.28, a PEG ratio of 1.43 and a beta of 0.54. The stock’s 50-day simple moving average is $485.84 and its 200 day simple moving average is $514.14.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, April 16th. The healthcare conglomerate reported $6.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $6.63 by $0.28. UnitedHealth Group had a return on equity of 26.50% and a net margin of 4.05%. The firm had revenue of $99.80 billion for the quarter, compared to analysts’ expectations of $99.23 billion. During the same quarter last year, the business earned $6.26 earnings per share. The company’s revenue was up 8.6% compared to the same quarter last year. As a group, analysts forecast that UnitedHealth Group Incorporated will post 27.61 earnings per share for the current fiscal year.

UnitedHealth Group Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, March 19th. Stockholders of record on Monday, March 11th were issued a dividend of $1.88 per share. This represents a $7.52 annualized dividend and a dividend yield of 1.52%. The ex-dividend date was Friday, March 8th. UnitedHealth Group’s dividend payout ratio (DPR) is presently 45.97%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.